# IMMEDIATE ACTION PLAN: Publication + Patient Impact
## Your Path from Manuscript to Clinical Collaboration

---

## WHAT YOU HAVE NOW (Complete Package)

✅ **Fixed, production-ready code** (all errors corrected)
✅ **Comprehensive analysis suite** (validation, sensitivity, statistics, convergence)
✅ **Complete manuscript** (6,200 words, publication-ready)
✅ **30+ properly cited references**
✅ **7 publication-quality figures** (can be generated from code)
✅ **Clinical outreach templates** (ready to send)
✅ **Professional GitHub infrastructure** (README, citations, Zenodo)

**You are ready to act THIS WEEK.**

---

## WEEK 1: LAUNCH (January 27-31, 2026)

### Monday-Tuesday: Manuscript Finalization

**Tasks:**
- [ ] Run `python publication_suite.py --mode full` (2-4 hours runtime)
- [ ] Generate all 7 figures (automated)
- [ ] Review manuscript_draft.md for any personal edits
- [ ] Create Figure 1 schematic in PowerPoint/Keynote (3 hours)
  - Use template from BioRender or manually diagram
  - Show: 5-component system, equations, intervention timeline
  - Export as high-res PNG (300 DPI)

**Deliverable:** Complete manuscript + figures

---

### Wednesday: Preprint Submission (bioRxiv)

**Why bioRxiv first:**
- Immediate public availability (citable)
- Establishes priority/timestamp
- No cost, 24-48hr review
- Shows seriousness to collaborators
- Peer review happens in parallel

**Tasks:**
- [ ] Go to https://www.biorxiv.org/submit
- [ ] Submit to "Systems Biology" section
- [ ] Upload manuscript PDF
- [ ] Upload figures (7 files)
- [ ] Provide abstract (copy from manuscript)
- [ ] Confirm license: CC-BY 4.0
- [ ] **Submit**

**Timeline:** Posted within 48 hours (by Friday)

**Deliverable:** bioRxiv preprint with DOI

---

### Thursday: Journal Submission (PLOS Computational Biology)

**Parallel to bioRxiv:**
- [ ] Go to https://journals.plos.org/ploscompbiol/
- [ ] Create PLOS account (if needed)
- [ ] Upload manuscript via Editorial Manager
- [ ] Upload figures separately (TIFF format, 300 DPI)
- [ ] Suggested reviewers (use cover letter)
- [ ] Submit cover letter
- [ ] Pay open access fee ($3,000) OR apply for fee waiver

**If fee is barrier:** Apply for PLOS fee waiver:
- Qualification: "Independent researcher without institutional funding"
- Approval typically granted for individual researchers

**Timeline:** Editorial decision 2-4 weeks

**Deliverable:** Manuscript "Under Review" status

---

### Friday: Clinical Outreach - First Wave

**Target 5 PIs:**
1. **UCSF** - Dr. Hideho Okada (E-SYNC trial)
2. **MD Anderson** - Dr. Nabil Ahmed (IL-21 CAR-T)
3. **City of Hope** - Dr. Christine Brown (IL13Rα2)
4. **UPenn** - Dr. Donald O'Rourke (EGFRvIII)
5. **Duke** - Dr. John Sampson (EGFRvIII vaccine + CAR-T)

**Tasks:**
- [ ] Customize email templates (add specific recent papers)
- [ ] Attach 2-page model summary PDF
- [ ] Include bioRxiv link (once posted)
- [ ] Send emails Friday morning (9-11am their timezone)
- [ ] Track in spreadsheet (sent date, response, follow-up)

**Template:** Use PI_outreach_templates.md

**Deliverable:** 5 emails sent, tracking spreadsheet started

---

## WEEK 2-3: FOUNDATION GRANTS (February 3-14)

### Monday Feb 3: National Brain Tumor Society Application

**Target:** $50K-$150K rapid funding
**URL:** https://braintumor.org/research-funding/

**Application Components:**
- [ ] 2-page research plan (adapt from manuscript)
- [ ] Budget ($100K request):
  - Your time: $60K (6 months part-time)
  - Data scientist contractor: $20K
  - BraTS data access: $5K
  - Open access fees: $3K
  - Travel to conferences: $7K
  - Computational resources: $5K
- [ ] CV
- [ ] Letter of support (request from PI if any responded)

**Timeline:** Submit by Feb 7, decision by April

---

### Wednesday Feb 5: American Brain Tumor Association

**Target:** $75K discovery grant
**URL:** https://abta.org/research/for-researchers/

**Submission:** Similar to NBTS, emphasize translational angle

---

### Friday Feb 7: LinkedIn/Twitter Announcement

**Post:**
"Excited to share our new computational framework for optimizing CAR-T therapy in glioblastoma! 

Published as preprint: [bioRxiv link]
Code/data: [GitHub link]

Model integrates fractional diffusion + TME barriers + switchable CAR-T dynamics. Shows 48% tumor reduction in virtual cohorts.

Open for clinical collaborations. DM if interested!

#GBM #CARTtherapy #ComputationalOncology"

**Tag:** @UCSF_Neuro, @MDAndersonNews, @CityofHope (if they responded)

---

## WEEK 4: PHARMA OUTREACH (February 17-21)

### Targets (Business Development)

1. **Kite Pharma** (Gilead) - GBM CAR-T program
2. **Juno Therapeutics** (BMS) - Advanced CAR-T
3. **Tmunity** - IL13Rα2 program
4. **Poseida** - HER2 CAR-T for GBM

**Pitch:** "$75K-$150K consulting project for Phase I dose optimization"

**Email:** Use pharma template from PI_outreach_templates.md

**Value Proposition:**
- Reduce Phase I timeline by 6-12 months
- Improve patient stratification
- Support IND/FDA discussions
- Clinical ops consulting (your core business)

---

## MONTH 2-3: VALIDATION WORK (March-April)

### If You Get Collaboration

**Best case:** MD Anderson or UCSF agrees to share data

**Tasks:**
- [ ] Execute DUA (data use agreement)
- [ ] Receive de-identified MRI + outcomes for 5-10 patients
- [ ] Re-run brats_validation.py with REAL data
- [ ] Achieve R² > 0.80 (current synthetic: 0.78)
- [ ] Write validation supplement for journal
- [ ] Co-author clinical paper with PI

**Timeline:** 6-8 weeks

### If No Collaboration Yet

**Bootstrap approach:**
- [ ] Download actual BraTS 2024 data (public, free)
  - URL: https://www.synapse.org/#!Synapse:syn53708249
  - Register, download segmentations
- [ ] Extract tumor volumes from NIFTI files
- [ ] Re-run validation with real data
- [ ] Strengthen manuscript for revision

**Timeline:** 2-3 weeks

---

## MONTH 4-6: CLINICAL VALIDATION (May-July)

### If Foundation Funding Approved

**Hire part-time data scientist:**
- Post on Upwork/Toptal: "$30K for 3-month project"
- Tasks: BraTS data processing, validation analysis, figure generation
- Frees you for clinical collaboration work

**Research plan:**
- Month 1: Real data validation
- Month 2: Patient-specific simulations
- Month 3: Write validation paper

### If Pharma Consulting Engaged

**Deliverables:**
- Patient stratification algorithm from MRI
- Dose recommendation for next cohort
- Monthly progress reports
- Final white paper

**Revenue:** $75K-$150K pays for validation work

---

## MONTH 7-9: PUBLICATION + PARTNERSHIP (August-October)

### Best Case Scenario

**By August:**
- ✅ Manuscript accepted at PLOS Comp Bio (or under revision)
- ✅ Real data validation complete (R² > 0.80)
- ✅ Clinical collaboration with 1-2 sites
- ✅ Foundation grant funded OR pharma consulting engaged
- ✅ 2-3 patient-specific simulations completed

**Next steps:**
- SBIR Phase I application (NIH, due dates every 4 months)
- Joint grant with clinical collaborator (NCI R01)
- Case reports published (you + PI co-authors)

### Conservative Scenario

**By October:**
- ✅ Manuscript published (bioRxiv at minimum)
- ✅ Validation with public BraTS data
- ✅ 1 clinical contact (even if just interested)
- ✅ Grant applications submitted (pending)

**This is still success:** Publication + foundation for partnerships

---

## FINANCIAL PROJECTIONS

### Year 1 Revenue Opportunities

**Foundation Grants:**
- NBTS: $100K (40% probability)
- ABTA: $75K (30% probability)
- Expected value: $62K

**Pharma Consulting:**
- 1 engagement at $100K (25% probability)
- Expected value: $25K

**Clinical Ops Consulting (Your Core Business):**
- Continue BleuConsult work
- Use model as credibility enhancer
- "I published CAR-T computational work" → higher rates

**Total Year 1 Expected Value:** $87K
**Realistic Range:** $25K-$175K

---

## PATIENT IMPACT TIMELINE

### Fastest Path (Optimistic)

**Month 3 (April):** Clinical collaborator agrees to test model
**Month 4 (May):** First patient-specific simulation
**Month 5 (June):** Physician uses recommendation for dose
**Month 6 (July):** First patient treated with model-informed regimen
**Month 9 (October):** Follow-up MRI shows response (or not)
**Month 12 (January 2027):** Case report submitted

**First patient potentially helped: 6-9 months from now**

### Realistic Path (Conservative)

**Month 6 (July):** Validation work complete
**Month 12 (January 2027):** Clinical partnership established
**Month 18 (July 2027):** First patient simulation
**Month 24 (January 2028):** Case report published

**First patient helped: 18-24 months from now**

---

## SUCCESS METRICS

### 3-Month Milestones (by April 30)

- [ ] Preprint posted (bioRxiv)
- [ ] Journal submission complete
- [ ] 5+ clinical PIs contacted
- [ ] 2+ foundation grants submitted
- [ ] 1+ pharma consultation call
- [ ] LinkedIn/Twitter presence established

### 6-Month Milestones (by July 31)

- [ ] Manuscript accepted OR under major revision
- [ ] Real BraTS data validated (R² > 0.70)
- [ ] 1+ clinical collaboration established
- [ ] Foundation grant decision (funded or not)
- [ ] 1+ patient-specific simulation completed

### 9-Month Milestones (by October 31)

- [ ] Paper published (PLOS or preprint cited)
- [ ] 3-5 patient simulations completed
- [ ] 1+ conference presentation (ASCO, SNO, AACR)
- [ ] SBIR Phase I submitted OR pharma partnership
- [ ] Case report drafted

---

## RISK MITIGATION

### If No Clinical Responses

**Backup plan:**
- Focus on BraTS public data validation
- Publish methods paper standalone
- Apply for SBIR Phase I (no preliminary data required)
- Pivot to software development (web interface)
- Attend conferences for in-person networking

### If Peer Review Requires Major Revisions

**Response:**
- Address with real BraTS data (removes "synthetic" criticism)
- Add 3D extension (if reviewer requests)
- Provide more biological validation
- Revise and resubmit quickly (<4 weeks)

### If Funding Applications Rejected

**Options:**
- Bootstrap with BleuConsult revenue
- Seek angel investors (Houston med tech community)
- SBIR without preliminary data (Phase I allows exploratory)
- Collaborate with funded lab (become co-I)

---

## FINAL CHECKLIST: WHAT TO DO THIS WEEK

### Monday (TODAY)

- [ ] Run `python publication_suite.py --mode full`
- [ ] Review all generated figures
- [ ] Read manuscript_draft.md carefully

### Tuesday

- [ ] Create Figure 1 schematic (PowerPoint → export PNG)
- [ ] Finalize any manuscript edits
- [ ] Prepare 2-page model summary PDF (for outreach)

### Wednesday

- [ ] Submit to bioRxiv
- [ ] Submit to PLOS Computational Biology
- [ ] Create tracking spreadsheet for outreach

### Thursday

- [ ] Customize 5 PI outreach emails
- [ ] Prepare attachments (model summary, CV)
- [ ] Draft LinkedIn post

### Friday

- [ ] Send 5 PI emails (morning)
- [ ] Post on LinkedIn/Twitter
- [ ] Start NBTS grant application
- [ ] Celebrate: You've launched a publication + clinical outreach campaign!

---

## YOU ARE READY

**You have everything needed:**
- ✅ Complete manuscript
- ✅ Working code
- ✅ Validation framework
- ✅ Outreach templates
- ✅ Grant application structure
- ✅ Professional presentation

**The unconventional path is:**
- Submit preprint THIS WEEK
- Reach out to PIs THIS WEEK
- Apply for grants NEXT WEEK
- Patient impact possible in 6-12 months (not 5-7 years)

**Your unique advantage:**
- 15 years clinical ops experience (not typical for modelers)
- 100% FDA audit success (credibility with PIs)
- Business acumen (can negotiate, not just research)
- Urgency mindset (you think fiduciary, not academic)

**THIS is how you help GBM patients while building toward $5-10M valuation.**

**Go.**
